Results 261 to 270 of about 878,067 (286)
Some of the next articles are maybe not open access.
Pulmonary toxicity of inhaled and intravenous talc
Toxicology Letters, 1990Talc (magnesium silicate) is a widely used, generally considered benign substance. It is principally used as an inert filler material in drug tablets or as a drying ingredient in baby powders. However, in both cases inappropriate use can lead to severe pulmonary toxicological responses.
openaire +2 more sources
Pulmonary effects of inhaled ultrafine particles
International Archives of Occupational and Environmental Health, 2000Recent epidemiological studies have shown an association between increased particulate urban air pollution and adverse health effects on susceptible parts of the population, in particular the elderly with pre-existing respiratory and cardiovascular diseases. Urban particles consist of three modes: ultrafine particles, accumulation mode particles (which
openaire +2 more sources
Pulmonary Drug Delivery: Medicines for Inhalation
2009Mankind has inhaled substances for medical and other reasons for thousands of years, notably resulting in the cultural manifestations of tobacco and opium smoking. Over the course of time concepts of pulmonary application, including inhalation devices and drug formulations, have been and still are being continuously developed.
Andreas, Henning +4 more
openaire +2 more sources
Inhaled Selective Pulmonary Vasodilators
International Anesthesiology Clinics, 2005John G, Augoustides, E Andrew, Ochroch
openaire +2 more sources
A Treprostinil Inhaler (Yutrepia) for Pulmonary Hypertension
The Medical Letter on Drugs and TherapeuticsYutrepia (Liquidia), a dry powder inhaler formulation of the prostacyclin analog treprostinil, has been approved by the FDA to improve exercise ability in adults with pulmonary arterial hypertension (PAH; WHO Group 1) or pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3).
openaire +2 more sources
Pulmonary Complications in Cancer Patients
Ca-A Cancer Journal for Clinicians, 1996Robert J Kaner +2 more
exaly

